Series C-stage Healthcare AI investors
Healthcare AI investors writing series c-stage checks. Cross-referenced with portfolio holdings, sub-vertical focus, and check-size range so you can shortlist credible leads for your raise.
Series C funding is secured by highly mature startups aiming to scale aggressively on a global scale, develop entirely new product ecosystems, or execute major corporate acquisitions. Investors participating in Series C rounds—including private equity firms, hedge funds, and investment banks—face lower operational risks and focus primarily on maximizing the company's valuation ahead of a liquidity event.
254
investors match
Within Series C: top healthcare sub-verticals
Mirae Asset Venture Investment
VC
AI
T3
AI/ML in Healthcare
Biotech
Mirae Asset Venture Investments
Corporate VC
T2
Digital Health
Molten Ventures
VC
T3
AI/ML in Healthcare
Biotech
Morningside Ventures
VC
T3
Biotech
Life Sciences Tools
MRCF
VC
T3
Biotech
Life Sciences Tools
Necessary Ventures
VC
T3
AI/ML in Healthcare
Biotech
NEOM Investment Fund (NIF)
PE
AI
T2
Biotech
Care Delivery / Tech-Enabled Services
Neva SGR
Corporate VC
AI
T3
AI/ML in Healthcare
Health IT / Healthcare Software
New Enterprise Associates (NEA)
VC
T1
AI/ML in Healthcare
Biotech
New Leaf Venture Partners
VC
T3
Biotech
Diagnostics
Norrsken22
VC
AI
T2
Digital Health
Health IT / Healthcare Software
Norwest Venture Partners
VC
T3
Biotech
Care Delivery / Tech-Enabled Services
Novartis Venture Fund
Corporate VC
T1
Biotech
Pharma / Therapeutics
Novastar Ventures
VC
T3
Care Delivery / Tech-Enabled Services
Digital Health
Novo Holdings
Corporate VC
AI
T3
Biotech
Life Sciences Tools